Stock & Company Details
Insulet Corporation $PODD
Price:
N/A
N/A
69M
$9.3B
52 Week High:
N/A
10 Day Average Volume:
N/A
25.16
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
Health Technology
PODD technical indicators
Latest Insulet Corporation (PODD) indicator readings as of 2026-10-09.
PODD's 14-day RSI is 44.7, in neutral territory. At $135.28 it is trading 28.6% below its 200-day moving average of $189.49, and below its 50-day average of $142.08. Price sits in the middle of its Bollinger Bands ($129.43 to $142.72). ADX reads 20.3, sitting between trending and range-bound.
PODD backtested strategy results
How 4 rule-based strategies performed on Insulet Corporation (PODD) over recent history, last backtested 2026-09-06. Select a strategy to plot its trades on the chart above. Past performance does not predict future results.
| Strategy | Equity curve | Return | Win rate | Trades | Max drawdown |
|---|---|---|---|---|---|
| Oversold Bounce Mean reversion Buy when RSI falls below 30 (oversold), sell when it climbs above 70 (overbought). | -8.1% | 33% | 15 | -56.7% | |
| Momentum Crossover Momentum Buy when MACD turns positive (crosses above zero) and RSI confirms momentum above 50; sell when MACD falls back below zero. | +36.0% | 42% | 24 | -44.0% | |
| Volatility Breakout Volatility Buy when price closes above the upper Bollinger Band, sell on reversion to the 20-day average. | -39.9% | 28% | 32 | -46.8% | |
| Strong-Trend Pullback Trend + timing In strongly trending stocks (ADX above 25), buy short-term dips (Stochastic below 30) and sell into overbought (above 80). | -52.6% | 41% | 32 | -73.2% |
Overview
Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device and that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the U.S. Food and Drug Administration in 2005, approximately 360,000 insulin-dependent diabetics are using it worldwide.
Finance Bot
Ask your questions
Start by typing a question below.
